Judge upholds $110M J&J talc verdict, despite SCOTUS jurisdiction ruling
Judge upholds 0M J&J talc verdict, despite SCOTUS jurisdiction ruling Johnson & Johnson’s string of talc wins has come to an end as a judge in Missouri upheld a $110 […]
Monthly Archives: November 2017
Could J&J's Darzalex success spur it to buy out partner Genmab? Maybe so, one analyst says
Could J&J’s Darzalex success spur it to buy out partner Genmab? Maybe so, one analyst says Wednesday, multiple myeloma medication Darzalex hit a development milestone, triggering a $20 million payment […]
After R&D spree, Bayer changes up research unit as Busch heads for the door
After R&D spree, Bayer changes up research unit as Busch heads for the door After penning research deals potentially worth billions of dollars this month, German pharma Bayer is looking […]
J&J, Gates Foundation and NIAID launch efficacy study for their 'global' HIV vaccine
J&J, Gates Foundation and NIAID launch efficacy study for their ‘global’ HIV vaccine As the scientific community continues to advance efforts to solve the global HIV and AIDS problem, Johnson […]
Sanofi takes €100M charge after Dengvaxia analysis leads it to seek smaller label
Sanofi takes €100M charge after Dengvaxia analysis leads it to seek smaller label After an analysis showed that Sanofi’s highly touted dengue vaccine could lead to more serious infections if used […]
Intestine grown from stem cells could improve on mouse models of gut disorders
Intestine grown from stem cells could improve on mouse models of gut disorders Scientists at Tufts University have created a 3D model of the human small intestine—an “organ on a […]
Duke engineers create fully functional beating heart patch
Duke engineers create fully functional beating heart patch After a heart attack, scar tissue that can’t contract typically replaces dead cardiac muscle, resulting in chronic heart failure—a scourge affecting 12 […]
Fresh off its Juluca approval, GlaxoSmithKline beefs up trials of long-acting HIV duo
Fresh off its Juluca approval, GlaxoSmithKline beefs up trials of long-acting HIV duo GlaxoSmithKline’s ViiV only just won its first two-drug HIV approval, but it’s already bolstering its trial program to […]
Pfizer's Prevnar 13 set for another price hike in 2018 as U.S. price-per-dose climbs near $180
Pfizer’s Prevnar 13 set for another price hike in 2018 as U.S. price-per-dose climbs near 0 Over the years, as Pfizer’s Prevnar 13 has grown into the company’s biggest product […]
Scangos recruits Washington University prof Virgin for Vir CSO role
Scangos recruits Washington University prof Virgin for Vir CSO role Vir Biotech CEO Geroge Scangos has lined up infectious disease and immunology expert Skip Virgin from Washington University as its […]